Hydroquinone + Mometasone Furoate + TretinoinThird Party Manufacturing in India

Hydroquinone + Mometasone Furoate + Tretinoin works by combining three distinct pharmacological mechanisms to treat melasma and hyperpigmentation.

Hydroquinone acts as a skin-depigmenting agent by inhibiting the enzymatic oxidation of tyrosine to 3,4-dihydroxyphenylalanine (DOPA) and suppressing other melanocyte metabolic processes, which ultimately decreases melanin production. Mometasone Furoate is a medium-potency topical corticosteroid that reduces the synthesis of inflammatory mediators, alleviating the skin irritation, redness, and itching often induced by the other two components. Tretinoin, a topical retinoid, binds to retinoic acid receptors to stimulate epidermal cell turnover and decrease the cohesion of follicular epithelial cells. This cell-turnover acceleration promotes the shedding of existing melanin-containing keratinocytes and facilitates the penetration of hydroquinone into the deeper layers of the skin.

Unlike single-ingredient depigmenting products, this triple-combination therapy works synergistically to achieve faster and more pronounced skin-lightening results. It is highly effective and well-tolerated when used for a limited duration under the supervision of a dermatologist.

Therapeutic Uses

Hydroquinone + Mometasone Furoate + Tretinoin is prescribed for the treatment of:

• Moderate-to-Severe Melasma: Lightens dark patches, discoloration, and hyperpigmentation on the face caused by hormonal changes, sun exposure, or pregnancy.
• Post-Inflammatory Hyperpigmentation: Fades dark marks and scars left behind by acne, injuries, or skin inflammation.
• Senile Lentigines (Age Spots): Reduces the appearance of stubborn age spots and sun-induced freckling in adult patients.

Why Manufacturers Choose Hydroquinone + Mometasone Furoate + Tretinoin

The triple-combination cream of Hydroquinone, Mometasone Furoate, and Tretinoin is one of the most widely prescribed dermatological treatments for stubborn hyperpigmentation in the Indian and export markets. This high-volume formulation offers contract manufacturers substantial commercial appeal due to its status as the gold standard for clinical melasma treatment.

Formulating a stable emulsion containing three active ingredients with different chemical stabilities—especially Tretinoin and Hydroquinone, which are sensitive to light and oxidation—requires specialized manufacturing expertise. Celesta's manufacturing partners utilize state-of-the-art nitrogen-purged equipment and advanced emulsification techniques to ensure stability, consistency, and elegant texture throughout the product's shelf life.

This makes the combination highly popular for third party manufacturing in India, with strong and steady demand from cosmetic dermatology brands, PCD franchise distributors, and international clients.